disorder

The Difference in Guanfacine Formulations for ADHD

By: Katharine Cimmino, Editor-in-Chief - Attention-deficit/hyperactivity disorder (ADHD) is the most common pediatric psychiatric disorder, and it affects the education,…

12 years ago

Recombinant Factor IX (Alprolix) Brings Hope for Hemophilia B Patients

By: Benedette Cuffari, BS Toxicology Candidate c/o 2015 - Hemophilia B is an inherited bleeding disorder that is caused by…

12 years ago

Off-Label Antidepressant Use in Pediatric Patients with Autism

By: Jacqueline Meaney, PharmD Candidate c/o 2015, University at Buffalo: School of Pharmacy and Pharmaceutical Sciences -- Psychotropic medications are…

12 years ago

FDA Approves Drug Elosulfase Alfa (Vimizim™) for Mucopolysaccharidosis (MPS IVA)

By: Erica Dimitropoulos Co-Copy Editor [Content- Focused]  - On February 14, 2014, elosulfase alfa (Vimizim™) became an FDA-approved enzyme replacement therapy…

12 years ago

The Surgeon General’s 2014 Report on Smoking

By: Ada Seldin, Staff Editor - Since the first release of the Surgeon General’s Report on smoking 50 years ago,…

12 years ago

Tasimelteon (Hetlioz®): First FDA Approved Pharmacologic Agent for Treatment of Non-24 in Completely Blind Individuals

By: Beatrisa Popovitz, Senior Staff Editor - On January 31st 2014, the FDA announced the release of a revolutionary new…

12 years ago

Psychiatric Prescriptions in the Fight Against Juvenile Diabetes

By: Davidta Brown, Senior Staff Editor - In August 2013, the results of a yearlong safety study were published in…

12 years ago

BRD4 Inhibition Eliminates Malignant Peripheral Nerve Sheath Tumor in Mice

By: Richard Chung, PharmD Candidate c/o 2017 - Malignant peripheral nerve sheath tumor, otherwise known commonly as MPNST, is an…

12 years ago

Asperger Syndrome: Temple Grandin’s Insight and Contribution

By: Sang Hyo Kim, Staff Editor - During the Fall 2013 semester, activist and bestselling author Temple Grandin, Ph.D, came…

12 years ago

Newly Approved: Macitentan (Opsumit®)

By: Rebecca Gilene, PharmD Candidate c/o 2014, St. Louis College of Pharmacy - The FDA approved macitentan (Opsumit®) on October…

13 years ago

“Cowcatcher” Enzyme Catching Medical Attention

By: Ansel Oommen, BS Toxicology Candidate c/o 2014 - DNA damage is the driving force behind aging, and, on a…

13 years ago

Nattokinase use in DVT prophylaxis

Samad Tirmizi, Pharm. D. Candidate c/o 2014 - Deep vein thrombosis (DVT) is a clot formation that occurs within deep…

13 years ago

BRAIN Initiative: Mapping the Human Brain

By Erica Dimitropoulos, Senior Staff Editor - If you were in charge of government spending, how would you allocate our…

13 years ago

Olmesartan Medoxomil Label Revision

By: David Ong, PharmD Candidate c/o 2014 - Manipulating the renin-angiotensin system is one of the many ways drugs are…

13 years ago

New Findings Regarding Cardiovascular Adverse Events with ADHD Medications

By: Aleena Cherian, Co-Copy Editor [Graphics-Focused] - Attention deficit/hyperactivity disorder (ADHD) is a chronic neurological behavior characterized by persistent patterns…

13 years ago

Alzheimer’s Disease On The Rise

By: Ada Seldin - An impending storm is threatening to stagger the health care system and the nation at large.…

13 years ago

New FDA Approval: Fycompa® to Treat Seizures

By: Bhavini Shah, PharmD Candidate c/o 2013  - Fycompa® (perampanel) has received the U.S. Food and Drug Administration (FDA) approval…

13 years ago

Liraglutide (Victoza®) for Type 2 Diabetes Mellitus

By:  Miriam Maltz, PharmD Candidate c/o 2013, AMSCOP, Long Island University - Type 2 diabetes mellitus (T2DM) is a metabolic…

13 years ago

FDA Approves Apixaban For Nonvalvular Atrial Fibrillation

By: Alexandra Alleva, PharmD candidate c/o 2013 - As of December 28th, Bristol-Myers Squibb and Pfizer's brand name oral anticoagulant,…

13 years ago

The Role of NMDA in Electroconvulsive Therapy and Other Neuropsychological Disorders

By: Neal Shah, Co-Editor-in-Chief - Electroconvulsive therapy (ECT) is a last-line procedure in the treatment of refractory depression, among other…

14 years ago

Matching Challenge: Over-the-Counter Products

By Mohamed Dungersi, Associate Student Editor - Match the following herbal products with their natural source and reason for use:…

14 years ago

The Pathology of Pure Red Cell Aplasia

By: Neal Shah, Co Editor-In-Chief - Pure Red Cell Aplasia (PRCA), also known as erythroblastopenia, is characterized by a suppression…

14 years ago

Matching Challenge: Look-Alike, Sound-Alikes

By: Addolorata Ciccone, Pharm.D. Candidate c/o 2013 - The following medications are easily confused.  Try to match each one with…

14 years ago

Korlym® For Endogenous Cushing’s Syndrome

By: Alexandra Alleva, Pharm.D. Candidate c/o 2013 - On February 17, 2012, the US Food and Drug Administration (FDA) approved…

14 years ago

The Diagnosis and Management of Bipolar Disorder in Children and Adolescents

By: Marie Huang - The amphitheater at Nassau University Medical Center fills up slowly as Dr. Alan Jay Cohen, a…

14 years ago

CHF, a Rare but Serious Presentation of Graves’ disease

By: James Schurr, Pharm.D. Candidate c/o 2014 - Graves’ disease is an autoimmune disorder that results in a state of…

14 years ago

Differences Between Antagonists and Inverse Agonists

By: Neal Shah - There are two major classifications of drug-receptor activity: agonism and antagonism. Agonism occurs when a molecule…

15 years ago